1-11 of 11
David H. Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer

Yang Xie, Wei Lu, Shidan Wang, Ximing Tang, Hao Tang, Yunyun Zhou, Cesar Moran, Carmen Behrens, Jack A. Roth, Qinghua Zhou, David H. Johnson, Stephen G. Swisher, John V. Heymach, Vassiliki A. Papadimitrakopoulou, Guanghua Xiao, John D. Minna, Ignacio I. Wistuba
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 150–157.
https://doi.org/10.1158/1078-0432.CCR-17-2543
Published: 03 January 2019
View article titled, Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer
Open the PDF for Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer in another window
Includes: Supplementary data
Journal Articles

A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer

Robert Mutter, Bo Lu, David P. Carbone, Ildiko Csiki, Luigi Moretti, David H. Johnson, Jason D. Morrow, Alan B. Sandler, Yu Shyr, Fei Ye, Hak Choy
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (6): 2158–2165.
https://doi.org/10.1158/1078-0432.CCR-08-0629
Published: 16 March 2009
View article titled, A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer
Open the PDF for A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non–Small Cell Lung Cancer in another window
Journal Articles

The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib

Mary J. Fidler, Athanassios Argiris, Jyoti D. Patel, David H. Johnson, Alan Sandler, Victoria M. Villaflor, John Coon, IV, Lela Buckingham, Kelly Kaiser, Sanjib Basu, Philip Bonomi
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (7): 2088–2094.
https://doi.org/10.1158/1078-0432.CCR-07-4013
Published: 01 April 2008
View article titled, The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib
Open the PDF for The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib in another window
Journal Articles

Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study

Afshin Dowlati, Robert Gray, Alan B. Sandler, Joan H. Schiller, David H. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1407–1412.
https://doi.org/10.1158/1078-0432.CCR-07-1154
Published: 03 March 2008
View article titled, Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study
Open the PDF for Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non–Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab—an Eastern Cooperative Oncology Group Study in another window
Includes: Supplementary data
Journal Articles

Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models

Jeffrey M. Albert, Carolyn Cao, Kwang Woon Kim, Christopher D. Willey, Ling Geng, Dakai Xiao, Hong Wang, Alan Sandler, David H. Johnson, Alexander D. Colevas, Jennifer Low, Mace L. Rothenberg, Bo Lu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 3033–3042.
https://doi.org/10.1158/1078-0432.CCR-06-2872
Published: 15 May 2007
View article titled, Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models
Open the PDF for Inhibition of Poly(ADP-Ribose) Polymerase Enhances Cell Death and Improves Tumor Growth Delay in Irradiated Lung Cancer Models in another window
Journal Articles

Targeted Therapies in Combination with Chemotherapy in Non–Small Cell Lung Cancer

David H. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4451s–4457s.
https://doi.org/10.1158/1078-0432.CCR-06-0095
Published: 20 July 2006
View article titled, Targeted Therapies in Combination with Chemotherapy in Non–Small Cell Lung Cancer
Open the PDF for Targeted Therapies in Combination with Chemotherapy in Non–Small Cell Lung Cancer in another window
Journal Articles

Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents

Thomas J. Lynch, Alex A. Adjei, Paul A. Bunn, Jr., Tim G. Eisen, Jeffrey Engelman, Glenwood D. Goss, Daniel A. Haber, John V. Heymach, Pasi A. Jänne, Bruce E. Johnson, David H. Johnson, Rogerio C. Lilenbaum, Matthew Meyerson, Alan B. Sandler, Lecia V. Sequist, Jeffrey Settleman, Kwok-Kin Wong, Carol S. Hart
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4365s–4371s.
https://doi.org/10.1158/1078-0432.CCR-06-1005
Published: 20 July 2006
View article titled, Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents
Open the PDF for Summary Statement: Novel Agents in the Treatment of Lung Cancer: Advances in Epidermal Growth Factor Receptor-Targeted Agents in another window
Journal Articles

Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer

A. Bapsi Chakravarthy, Mark C. Kelley, Bernadette McLaren, Cristina I. Truica, Dean Billheimer, Ingrid A. Mayer, Ana M. Grau, David H. Johnson, Jean F. Simpson, R. Daniel Beauchamp, Catherine Jones, Jennifer A. Pietenpol
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (5): 1570–1576.
https://doi.org/10.1158/1078-0432.CCR-05-2304
Published: 06 March 2006
View article titled, Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer
Open the PDF for Neoadjuvant Concurrent Paclitaxel and Radiation in Stage II/III Breast Cancer in another window
Journal Articles

Targeting Cyclooxygenase-2 in Recurrent Non–Small Cell Lung Cancer: A Phase II Trial of Celecoxib and Docetaxel

Ildiko Csiki, Jason D. Morrow, Alan Sandler, Yu Shyr, John Oates, Myles K. Williams, Thao Dang, David P. Carbone, David H. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6634–6640.
https://doi.org/10.1158/1078-0432.CCR-05-0436
Published: 15 September 2005
View article titled, Targeting Cyclooxygenase-2 in Recurrent Non–Small Cell Lung Cancer: A Phase II Trial of Celecoxib and Docetaxel
Open the PDF for Targeting Cyclooxygenase-2 in Recurrent Non–Small Cell Lung Cancer: A Phase II Trial of Celecoxib and Docetaxel in another window
Journal Articles

Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer

Alan B. Sandler, David H. Johnson, Roy S. Herbst
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4258s–4262s.
https://doi.org/10.1158/1078-0432.CCR-040023
Published: 15 June 2004
View article titled, Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer
Open the PDF for Anti-Vascular Endothelial Growth Factor Monoclonals in Non-Small Cell Lung Cancer in another window
Journal Articles

Weekly Irinotecan and Cisplatin in Advanced Non-Small Cell Lung Cancer: A Multicenter Phase II Study

Madan H. Jagasia, Corey J. Langer, David H. Johnson, Furhan Yunus, John S. Rodgers, Larry L. Schlabach, Alan G. Cohen, Yu Shyr, David P. Carbone, Russell F. DeVore
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (1): 68–73.
Published: 01 January 2001
View article titled, Weekly Irinotecan and Cisplatin in Advanced Non-Small Cell Lung Cancer: A Multicenter Phase II Study
Open the PDF for Weekly Irinotecan and Cisplatin in Advanced Non-Small Cell Lung Cancer: A Multicenter Phase II Study in another window